Home / Import refusals / AEK-0593779-1/10002/8

FDA Import Refusal AEK-0593779-1/10002/8 — Ajanta Pharma Ltd.

Ajanta Pharma Ltd. — FEI 3006785788

The FDA refused shipment AEK-0593779-1/10002/8 from Ajanta Pharma Ltd. (India) on May 26, 2026. The refused product falls under Drugs and Biologics — FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 26, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
66TAA03 FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR)
Charges
75

Recent inspections

  • 1313426 (VAI Tue Apr 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1235564 (NAI Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097061 (VAI Fri Jun 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009806 (VAI Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 917795 (VAI Fri Mar 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-3441591-9/20002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0616004-7/10002/1 (Fri Jun 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9441345-5/10003/1 (Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2495006-9/10003/1 (Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7952222-1/90003/1 (Fri Dec 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources